TY - JOUR
T1 - Optimizing Shigella isolation
T2 - a multi-site evaluation of laboratory culture methods for Shigella detection, speciation, and serotyping with different transport media and sample types in the Enterics for Global Health study
AU - EFGH Consortium
AU - Bhuiyan, Md Taufiqur Rahman
AU - Liu, Jie
AU - Juma, Jane
AU - Horne, Bri'Anna
AU - Hotwani, Aneeta
AU - Badji, Henry
AU - Maiden, Victor Adrian
AU - Ochieng, John Benjamin
AU - Romaina-Cachique, Lucero A.
AU - Aluoch, Laura Riziki
AU - Ambila, Lilian Achieng
AU - Aziz, Fatima
AU - Charles, Mary
AU - Feutz, Erika L.
AU - Garcia Bardales, Paul F.
AU - Hossain, M. Jahangir
AU - Iqbal, Junaid
AU - Islam, Md Taufiqul
AU - Jabang, Abdoulie
AU - Jarju, Sheikh
AU - Jere, Khuzwayo C.
AU - Kabir, Furqan
AU - Kawonga, Flywell
AU - Keita, Adama Mamby
AU - Khanam, Farhana
AU - Villanueva, Katia Manzanares
AU - Mosharraf, Md Parvej
AU - Omore, Richard
AU - Olortegui, Maribel Paredes
AU - Pavlinac, Patricia B.
AU - Platts-Mills, James A.
AU - Rogawski McQuade, Elizabeth T.
AU - Saidi, Queen
AU - Sears, Khandra T.
AU - Tapia, Milagritos D.
AU - Traore, Awa
AU - Qadri, Firdausi
AU - Yori, Pablo Penataro
AU - Qamar, Farah Naz
AU - Sow, Samba O.
AU - Kotloff, Karen L.
AU - Tennant, Sharon M.
AU - Houpt, Eric R.
AU - Cornick, Jennifer
AU - Secka, Ousman
AU - Ahmed, Dilruba
AU - Anyango, Raphael
AU - Apondi, Evans
AU - Atlas, Hannah E.
AU - Fatima, Irum
N1 - Publisher Copyright:
Copyright © 2026 Bhuiyan et al.
PY - 2026/4
Y1 - 2026/4
N2 - Shigella is a leading cause of diarrhea and dysentery in children younger than 5 years of age in low-resource settings, and several vaccines are in development. Due to its fastidious nature, Shigella can be difficult to culture, and eventual vaccine trials will need to optimize the isolation of Shigella to ensure efficient sample sizes. In the recently concluded Enterics for Global Health (EFGH) Shigella Surveillance study, we compared Shigella culture isolation rates between rectal swab vs. whole stool, between two swabs vs. one, and between Cary Blair (CB) vs. modified-Buffered Glycerol Saline (mBGS) transport media to identify the optimal methods for Shigella recovery by microbiologic culture. Among 9,476 children aged 6–35 months enrolled in the EFGH study from seven country sites, Shigella isolation rates did not differ significantly between CB (7.8%) and mBGS (7.9%) (P > 0.99). Using two swabs improved the detection rates (9.3%), compared with one swab (7.9%) (P < 0.001). Among the 2,048 children from Bangladesh and The Gambia, where both rectal swabs and whole stool were collected from the same children, rectal swabs were found to be non-inferior to whole stool for Shigella culture (12.4% and 12.7%, respectively, with a difference of −0.29% [95% CI: −0.83% to 0.24%]). To optimize Shigella recovery for future multi-country vaccine trials, we recommend collecting two flocked rectal swabs in CB or mBGS media with strict adherence to transit conditions—an approach proven feasible across EFGH sites.
AB - Shigella is a leading cause of diarrhea and dysentery in children younger than 5 years of age in low-resource settings, and several vaccines are in development. Due to its fastidious nature, Shigella can be difficult to culture, and eventual vaccine trials will need to optimize the isolation of Shigella to ensure efficient sample sizes. In the recently concluded Enterics for Global Health (EFGH) Shigella Surveillance study, we compared Shigella culture isolation rates between rectal swab vs. whole stool, between two swabs vs. one, and between Cary Blair (CB) vs. modified-Buffered Glycerol Saline (mBGS) transport media to identify the optimal methods for Shigella recovery by microbiologic culture. Among 9,476 children aged 6–35 months enrolled in the EFGH study from seven country sites, Shigella isolation rates did not differ significantly between CB (7.8%) and mBGS (7.9%) (P > 0.99). Using two swabs improved the detection rates (9.3%), compared with one swab (7.9%) (P < 0.001). Among the 2,048 children from Bangladesh and The Gambia, where both rectal swabs and whole stool were collected from the same children, rectal swabs were found to be non-inferior to whole stool for Shigella culture (12.4% and 12.7%, respectively, with a difference of −0.29% [95% CI: −0.83% to 0.24%]). To optimize Shigella recovery for future multi-country vaccine trials, we recommend collecting two flocked rectal swabs in CB or mBGS media with strict adherence to transit conditions—an approach proven feasible across EFGH sites.
KW - gastrointestinal infections
KW - global child health
KW - global health
KW - infectious diseases
KW - pediatric infectious diseases
UR - https://www.scopus.com/pages/publications/105034225146
U2 - 10.1128/jcm.01279-25
DO - 10.1128/jcm.01279-25
M3 - Article
C2 - 41746130
AN - SCOPUS:105034225146
SN - 0095-1137
VL - 64
JO - Journal of Clinical Microbiology
JF - Journal of Clinical Microbiology
IS - 4
ER -